UBR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.729400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.560200E-01
Normal-vs-Stage2
3.008000E-01
Normal-vs-Stage3
1.043780E-01
Normal-vs-Stage4
9.271000E-01
Stage1-vs-Stage2
6.913600E-01
Stage1-vs-Stage3
3.208400E-01
Stage1-vs-Stage4
2.362400E-01
Stage2-vs-Stage3
1.439040E-01
Stage2-vs-Stage4
1.726630E-01
Stage3-vs-Stage4
4.861600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.599400E-01
Normal-vs-AfricanAmerican
4.553400E-01
Normal-vs-Asian
4.294400E-01
Caucasian-vs-AfricanAmerican
8.949600E-01
Caucasian-vs-Asian
9.454200E-01
AfricanAmerican-vs-Asian
8.998800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.913400E-01
Normal-vs-Female
2.689000E-01
Male-vs-Female
8.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.459400E-01
Normal-vs-Age(41-60Yrs)
4.744600E-01
Normal-vs-Age(61-80Yrs)
1.797180E-01
Normal-vs-Age(81-100Yrs)
4.954600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.525000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.027200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.937200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.378300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.707200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.832990E-01
Normal-vs-Daily Drinker
3.764400E-02
Normal-vs-Weekly Drinker
3.586200E-01
Normal-vs-Occasional Drinker
5.426400E-01
Normal-vs-Social Drinker
4.354200E-01
Non Drinker-vs-Daily Drinker
4.471600E-02
Non Drinker-vs-Weekly Drinker
8.369400E-01
Non Drinker-vs-Occasional Drinker
2.266600E-01
Non Drinker-vs-Social Drinker
5.171200E-01
Daily Drinker-vs-Weekly Drinker
9.369500E-02
Daily Drinker-vs-Occasional Drinker
7.304700E-03
Daily Drinker-vs-Social Drinker
3.452300E-02
Weekly Drinker-vs-Occasional Drinker
4.670400E-01
Weekly Drinker-vs-Social Drinker
7.477200E-01
Occasional Drinker-vs-Social Drinker
6.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.242370E-01
Normal-vs-Grade 2
2.717900E-02
Normal-vs-Grade 3
2.970100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.814100E-02
Grade 1-vs-Grade 3
4.099800E-02
Grade 1-vs-Grade 4
1.242370E-01
Grade 2-vs-Grade 3
3.942400E-01
Grade 2-vs-Grade 4
2.717900E-02
Grade 3-vs-Grade 4
2.970100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.539000E-01
Normal-vs-NonDiabetic
2.215400E-01
Diabetic-vs-NonDiabetic
4.473400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.051400E-01
Normal-vs-NoPancreatitis
2.170000E-01
Pancreatitis-vs-NoPancreatitis
7.529800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.822400E-01
Normal-vs-N1
2.914600E-01
N0-vs-N1
8.503800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.767400E-01
Normal-vs-TP53-NonMutant
5.773200E-01
TP53-Mutant-vs-TP53-NonMutant
5.061400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
